Safety and Efficacy Associated With Treating Erectile Dysfunction Patients With Low Intensity Shockwaves by Renova
Not Applicable
Terminated
- Conditions
- Vasculogenic Erectile Dysfunction
- Interventions
- Device: Low Intensity Shockwave by RenovaDevice: Sham treatment
- Registration Number
- NCT01811797
- Lead Sponsor
- Initia
- Brief Summary
This is a prospective, randomized, double-blind clinical study comparing safety and efficacy of the treatments performed with the Low Intensity Extracorporeal Shockwave Therapy (LI-ESWT) device - "Renova" on symptomatic ED patients to the safety and efficacy of the control sham patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Male
- Target Recruitment
- 2
Inclusion Criteria
- Good general health
- Vascular ED for at least 6 months
- International Index of Erectile Function 6 (IIEF-EF) between 11 to 25
- Positive response to PDE5-I (able to penetrate on demand=Responders)
- Negative response to PDE5-I (unable to penetrate on demand even with maximum PDE5-I dosage = Non-responders)
- Stable heterosexual relationship for more than 3 months
Exclusion Criteria
- Hormonal, neurological or psychological pathology
- Past radical prostatectomy or extensive pelvic surgery
- Recovering from cancer during last 5 years
- Any unstable medical, psychiatric, spinal cord injury and penile anatomical abnormalities
- Clinically significant chronic hematological disease
- Anti-androgens, oral or injectable androgens
- Past radiotherapy treatment of the pelvic region
- International normalized ratio (INR) > 3 for patients using blood thinners (such as Coumadin)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Low Intensity Shockwave treatment Low Intensity Shockwave by Renova 4 weekly sessions of Low Intensity Shockwave treatment. Control group Sham treatment -
- Primary Outcome Measures
Name Time Method Change from baseline in the IIEF-EF (International Index of Erectile Function- Erectile Function Domain) score at 3 and 6 months post treatment 1, 3 and 6 months post treatment
- Secondary Outcome Measures
Name Time Method Change from baseline in the SEP (Sexual Encounter Profile) Questions 2 and 3 at 3 and 6 months post treatment 1, 3 and 6 months post treatment Change from baseline in the GAQ (Global Assessment Questions) at 3 and 6 months post treatment 1, 3 and 6 months post treatment Change from baseline in the EDITS (Erectile Dysfunction Inventory of Treatment Satisfaction) score at 3 and 6 months post treatment 1, 3 and 6 months post treatment Change from baseline in the Partner EDITS (Erectile Dysfunction Inventory of Treatment Satisfaction) score at 3 and 6 months post treatment 1, 3 and 6 months post treatment Change from baseline in the IPSS (International Prostate Symptom Score) at the end of the treatment 0 and 6 months post treatment
Trial Locations
- Locations (1)
The Tel-Aviv Sourasky Medical Center
🇮🇱Tel-Aviv, Israel